Spin-off Pitches - Quickfire Round

Discover promising spin-off projects from across Helmholtz Health and beyond, developing innovative solutions in therapeutics, vaccines, regenerative medicine, biotechnology and digital research tools.

Each team will have 3 minutes to pitch, the jury and audience select the Top 3 finalists, who will compete in the afternoon finals at 17:00.

Meet the pitching teams

1. EBViously – Developing a next-generation virus-like particle vaccine against Epstein-Barr virus-associated diseases.

2. Arvalus Therapeutics – Preventing life-threatening infections by targeting the microbiota with a live biotherapeutic product (LBP) against multidrug-resistant Enterobacteriaceae.

3. MiPath - Enabling precision nutrition through functional microbiome profiling.

4. INTERDEL – Developing inhaled formulations designed to improve how medicines distribute through the lung after deposition.

5. Airiva – Developing a first-in-class, epigenetically acting, disease-modifying drug for inflammatory respiratory diseases.

6. Glitch Therapeutics – Developing programmable RNA-editing therapies that generate immunogenic neoepitopes directly in cancer cells, turning tumors into targets for precise T-cell recognition.

7. Citrapeutics – Restoring anti-tumor immunity across multiple solid tumor indications.

8. Allothera – Treating neuropathic pain at its source.

9. Volumetric Engineering – Taking (not just) microscopy out of flatland – developing a platform for Extended Reality/Spatial Computing-based lab hardware control and visualisation.

10. NEURO-STEM – Turning blood into brain repair: scalable, off-the-shelf directly reprogrammed neural stem cells for neurological diseases.

11. NovInCell – Protecting the brain from stroke effects by making its vascularisation more stable.

Meet the jury

• Maria Fernandez Albizuri – Head of Life Sciences and Health at DEEP Institute, ESMT Berlin, and Director, CDL-Berlin and CDL-Doha

• Anela Vukoja – Partner, i&i Bio

• Ralf Angermund – Director Search & Evaluation Germany, Johnson & Johnson Innovative Medicine

Moderated by Kseniia Choni, Business Development Manager at Max Delbrück Center.

Don't miss the opportunity to discover emerging biotech ventures, meet the teams behind them and vote for your favourite spin-off project!